Literature DB >> 17108705

Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis?

P van Paassen1, J W Cohen Tervaert, P Heeringa.   

Abstract

Both the innate and the acquired immune system are involved in the pathophysiology of renal vasculitis. However, anti-neutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis is characterized by a 'pauci-immune' pattern of immunofluorescence during kidney biopsy, indicating the relative lack of immunoglobulin and complement deposition within the kidney. On the other hand, evidence is accumulating that ANCA, autoantibodies against constituents of primary granules of neutrophils and the lysosomes of monocytes, play a pathogenic role in renal vasculitis. In this review we will discuss both in vitro and in vivo experimental data providing compelling evidence that ANCA are a primary pathogenic factor in renal vasculitis, mainly by augmenting leukocyte-endothelial interactions. We will also address novel data, pointing at the role of, in addition to ANCA, non-specific proinflammatory signals. Finally, we propose a working hypothesis of the pathogenesis of ANCA-associated renal vasculitis. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17108705     DOI: 10.1159/000096960

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  12 in total

1.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 2.  T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

Authors:  Benjamin Wilde; Marielle Thewissen; Jan Damoiseaux; Pieter van Paassen; Oliver Witzke; Jan Willem Cohen Tervaert
Journal:  Arthritis Res Ther       Date:  2010-02-24       Impact factor: 5.156

3.  Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN.

Authors:  Diana S Y Tan; Poh Y Gan; Kim M O'Sullivan; Maree V Hammett; Shaun A Summers; Joshua D Ooi; Brita A Lundgren; Richard L Boyd; Hamish S Scott; A Richard Kitching; Ann P Chidgey; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 10.121

Review 4.  Treatment of renal manifestations of ANCA-associated vasculitis.

Authors:  Kresimir Galesic; Danica Ljubanovic; Ivica Horvatic
Journal:  J Nephropathol       Date:  2013-01-01

5.  MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits.

Authors:  Kei Matsumoto; Hirokazu Honda; Takanori Shibata; Daisuke Sanada; Yukihiro Wada; Eijin Ashikaga; Aki Kuroki; Kozo Kitazawa; Tadao Akizawa
Journal:  NDT Plus       Date:  2009-08-24

6.  Fulminant primary manifestations of Wegener's granulomatosis might not be pauci-immune.

Authors:  Ulf Schönermarck; Maja Grahovac; Miklós Sárdy; Michael Dolch; Andreas Wollenberg
Journal:  NDT Plus       Date:  2010-08-05

7.  A rare association between Fabry's disease and granulomatosis with polyangiitis: a potential pathogenic link.

Authors:  Hironari Hanaoka; Akinori Hashiguchi; Konosuke Konishi; Tomohiro Ishii; Masataka Kuwana
Journal:  BMC Nephrol       Date:  2014-10-01       Impact factor: 2.388

8.  Oral manifestations of granulomatosis with polyangiitis - Clinical and radiological assessment.

Authors:  Katarzyna Szczeklik; Anna Włudarczyk; Katarzyna Wawrzycka-Adamczyk; Jacek Górka; Maria Fuks-Kulska; Dagmara Darczuk; Jolanta Pytko-Polończyk; Wojciech Szczeklik
Journal:  J Dent Sci       Date:  2018-11-27       Impact factor: 2.080

Review 9.  Vasculitis in Cystic Fibrosis.

Authors:  Francesca Sposito; Paul S McNamara; Christian M Hedrich
Journal:  Front Pediatr       Date:  2020-11-12       Impact factor: 3.418

Review 10.  Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.

Authors:  Jérôme Granel; Brice Korkmaz; Dalila Nouar; Stefanie A I Weiss; Dieter E Jenne; Roxane Lemoine; Cyrille Hoarau
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.